Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

CNBX — CNBX Pharmaceuticals Inc. SEC Filings | FilingIndex

CNBXOTC

CNBX Pharmaceuticals Inc.

Pharmaceutical Preparations · NV · CIK 1343009

CNBX Pharmaceuticals Inc. develops and commercializes innovative pharmaceutical products

+ Watch View on EDGAR ↗

181

Total filings

Jun 24, 2026

Last filing

08/31

Fiscal year end

All 8-K · 79 10-Q · 54 10-K · 17 10-Q/A · 9 SC 13D · 5 S-1 · 4 10-K/A · 4 S-1/A · 4

10-QFORM 10-Q FOR MAY 2026Jun 24, 2026 10-QFORM 10-QApr 14, 2026 8-KMaterial AgreementMar 17, 2026 10-QQUARTERLY REPORTJan 14, 2026 10-KFORM 10-K FOR AUG 2025Dec 1, 2025

Similar companies

Comparable business profile · signals at a glance

MBXMBX Biosciences, Inc.$1.7B+2.5%RGNXREGENXBIO Inc.$344.3M+1.3%DWTXDogwood Therapeutics, Inc.$51.8M-9.6%HELPCYBIN INC.$214.5M-3.9%CTNMContineum Therapeutics, Inc.

10-Q

FORM 10-Q

Jul 14, 2025

10-Q10-QApr 14, 2025

8-KMaterial AgreementJan 30, 2025

10-QFORM 10-Q FOR NOV 2024Jan 13, 2025

10-KFORM 10-K FOR AUGUST 2024Nov 29, 2024

10-QFORM 10-QJul 15, 2024

10-QFORM 10-Q FOR FEBRUARY 2024Apr 16, 2024

8-KAuditor ChangeMar 22, 2024

10-QQUARTERLY REPORTJan 12, 2024

10-KFORM 10-K FOR AUG 2023Nov 30, 2023

10-QQUARTERLY REPORTJul 14, 2023

10-QQUARTERLY REPORTApr 14, 2023

SC 13GSC 13GMar 6, 2023

8-KExecutive ChangeFeb 8, 2023

10-QFORM 10-QJan 13, 2023

8-KExecutive ChangeDec 29, 2022

10-KFORM 10-KNov 30, 2022

8-KExecutive ChangeJul 25, 2022

10-QFORM 10-QJul 14, 2022

8-KBylaw AmendmentMay 13, 2022

10-QFORM 10-QApr 12, 2022

8-KBylaw Amendment · Company UpdateMar 28, 2022

8-KMaterial Agreement · New Debt / ObligationMar 16, 2022

S-1FORM S-1Feb 18, 2022

8-KMaterial AgreementFeb 17, 2022

10-QFORM 10-QJan 13, 2022

10-K10-KNov 29, 2021

8-KExecutive ChangeNov 19, 2021

8-KExecutive ChangeSep 13, 2021

8-KExecutive ChangeJul 19, 2021

10-QFORM 10-QJul 14, 2021

8-KExecutive ChangeJul 6, 2021

S-1FORM S-1May 10, 2021

8-KMaterial AgreementApr 28, 2021

10-QQUARTERLY REPORTApr 14, 2021

S-1/AFORM S-1 AMENDMENTFeb 23, 2021

S-1REGISTRATION STATEMENTJan 27, 2021

10-QFORM 10-QJan 14, 2021

8-KMaterial AgreementDec 21, 2020

8-KReg FD DisclosureNov 16, 2020

10-KANNUAL REPORTNov 4, 2020

8-KExecutive ChangeSep 2, 2020

10-QFORM 10-QJul 14, 2020

8-KReg FD DisclosureApr 17, 2020

8-KExecutive ChangeApr 17, 2020

10-QFORM 10-QApr 13, 2020

10-QFORM 10-QJan 14, 2020

10-KFORM 10-KNov 29, 2019

8-KChange of ControlNov 8, 2019

8-KAuditor ChangeNov 7, 2019

8-KExecutive ChangeOct 11, 2019

8-KExecutive ChangeOct 7, 2019

8-KExecutive ChangeOct 3, 2019

8-KAuditor ChangeJul 23, 2019

10-QFORM 10-QJul 15, 2019

8-KExecutive ChangeJun 25, 2019

10-QFORM 10-QApr 15, 2019

8-KMaterial Agreement · Equity IssuanceFeb 13, 2019

10-QFORM 10-QJan 17, 2019

10-KANNUAL REPORTNov 29, 2018

8-KMaterial Agreement · Equity IssuanceSep 27, 2018

424B5424B5Sep 26, 2018

8-KMaterial AgreementAug 14, 2018

10-QFORM 10-QJul 16, 2018

8-KMaterial AgreementMay 2, 2018

10-QFORM 10-QApr 5, 2018

8-KExecutive ChangeFeb 14, 2018

8-KExecutive ChangeJan 30, 2018

10-QFORM 10-QJan 16, 2018

8-KMaterial AgreementDec 19, 2017

10-KFORM 10-KDec 8, 2017

8-KAuditor ChangeNov 13, 2017

8-KExecutive ChangeNov 13, 2017

10-QFORM 10-QJul 17, 2017

8-KMaterial AgreementMay 10, 2017

$444.2M

+9.3%

CLNNClene Inc.$74.6M-2.8%